Number of Patients, Male	33
Number of Patients, Female	9
Stage	Stage IV: 42 (100%)
Age	Median (range): 56.6 (36–78) years
Number of Prior Systemic Therapies	Median (range): 3 (2–7)
Performance Status: ECOG	0 — 19 1 — 19 2 — 3 3 — 0 Unknown — 0
Cancer Types or Histologic Subtypes	BRAF mutated — 0 BRAF wild type — 12 (31%) KRAS mutated — 21 (50%) KRAS wild type — 18 (42.9%) Microsatellite instability (MSI) high — 0 MSI low — 1 (2.4%) MSI stable — 12 (28.6%)
Other	See Table 2 and Figure 2.